[e-drug] RFI: cost-utility of anti-TNF therapies in RA

e-drug
1

E-DRUG: RFI: cost-utility of anti-TNF therapies in RA
----------------------------------------------------

Hallo,

I need your assistance. I am currently undertaking a
cost utility study on the new antiTNF
therapies(etanercept and infliximab) and leflunimide
used in the treatment of rheumatoid arthritis.

Any imformation on the sources of costs and
effectiveness estimates and suggestions on sources of
data (in the UK) will be welcome.

Thanks

Dr.Anthony Kamau Njuguna,
Chief Pharmacist,
Strategis Health Kenya Ltd
kamaupharm@yahoo.com

--
To send a message to E-Drug, write to: e-drug@healthnet.org
To subscribe or unsubscribe, write to: majordomo@healthnet.org
in the body of the message type: subscribe e-drug OR unsubscribe e-drug
To contact a person, send a message to: e-drug-help@healthnet.org
Information and archives: http://www.essentialdrugs.org/edrug